Regional Victorian Trials Alliance:
Linkages, Innovation, Special populations, Equity

The ReViTALISE project is funded by a $18.6m Medical Research Future Fund (MRFF) grant, under the Rural, Regional and Remote Clinical Trial Enabling Infrastructure Fund.
Running over 5 years, the project is administered by the Border Medical Oncology Research Unit, working with the Regional Trials Network Victoria (RTN-Vic).
Our Goal:
- Equal access to high-quality cancer care for regional and rural Victorians, leading to better health outcomes.
- Bridging the metropolitan-regional trials gap by 2025, bringing the regional participation rates in line with metropolitan rates.
- Better cancer outcomes for regional Victorians by increasing regional trial participation rates.

Bridging the metro-regional trials gap by 2025
In 2017, of the 1587 Victorian cancer clinical trial patients, only 27% were rural residents, and of those, only 81 patients participated at a rural site (based on 2017 Cancer Council Victoria Clinical Trial Management System).
The ReViTALISE project aims to increase clinical trial participation in regional and rural Victoria by supporting new or fledgling regional sites, building capability and capacity, increasing clinical trial activity in areas of unmet need, and upskilling the regional workforce.
ReViTALISE builds on the success of the Regional Trials Network Victoria (RTN-Vic). It addresses the disparity in regional cancer care and clinical research by focusing on seven key areas:
- Expanding the existing Research Trial Network from six sites to eight, servicing the Mallee and Gippsland regions.
- Pallative & Supportive Care research programs to improve patient outcomes.
- Aboriginal and Torres Strait Islander Clinical Trial Access Programs.
- Immunotherapy Trials and education into immunotherapy treatment.
- Registry Trials to collect data from our specific patient populations to identify future research and treatment needs.
- Geriatric Oncology to meet the needs of the aging regional population.
- Establishing a
Regional Research Teaching Hub to support staff in the upskilling required to conduct meaningful research in regional and rural settings.
Our Project Team
The ReViTALISE project spans rural and regional Victoria, to the far west of Mildura and the Mallee, to the South towards Warrnambool, and to the East across to Gippsland, managed by the ReViTALISE team from the Border Medical Oncology Research Unit. To get in touch, email us at contact@regionaltrialsnetwork.org

Regional Onocology Lead
A/Prof Craig Underhill

Senior Project Advisor
Suiyin Cheah

ReViTALISE Business Manager
Fiona Tuthill

REVITALISE Project Officer
Damon Parker

REVITALISE PROJECT MANAGER
Donna Long
ReViTALISE Initiatives
ReViTALISE aims to address the specific needs of regional and rural Victorians, across a variety of different initiatives, each led by a Regional Victorian Health Service.
Every Voice Consumer Advisory Network
The ReViTALISE consumer advisory group, Every VoiceCAN was created by a ReViTALISE consumer to support and empower regional consumers involved in ReViTALISE Initiatives.
This group facilitates information sessions on ReViTALISE Initiatives and encourages consumers to provide their perspectives and share their experiences.

Expand Regional Trials Network
Led by Latrobe Regional Health & Mildura Base Hospital
Increase the Regional Trials Network (RTN).
Prior to the RTN, there were vast populations of regional Victorians not served by centres able to conduct research.
ReViTALISE aims to assist Mildura Base Hospital and Latrobe Regional Health to build both capability and capacity, by leveraging mentorship from other regional network member sites, and ultimately delivering research to under-served Victorians.
The Expand initiative will allow Victorians in the Mallee, Wimmera Southern Mallee and Gippsland regions to access cancer research without travelling too far from home.


Pallative & Supportive Care
Led by Barwon Health and South West Healthcare, Warnnambool & University of Melbourne
Increase the number of pallative and supportive care trials in regional areas and increase trials in regional sites.
Regional palliative patients and those needing supportive care have additional challenges in the management of their care.
The Pallative & Supportive Care initiative sets out to increase the number of palliative and supportive care patients participating in clinical trials in their regional areas.
The initiative also aims to increase awareness and participation in clinical research across the palliative care workforce.
Aboriginal and Torres Strait Islander Clinical Trial Access Initiative
Led by Goulburn Valley Health, Shepparton
Co-designing a pilot with consumers, local health groups and researchers to increase cancer clinical trial participation among the Aboriginal and Torres Strait Islander communities.
The implementation of the Clinical Trials component of the Optimal Care Pathways for Aboriginal and Torres Strait Islander People with Cancer represents a potential major shift in heath outcomes for these communities.
Successful completion of this initiative will result in a completed pilot at Goulburn Valley Health, Shepparton, along with long term sustainability plans for bridging the health gap for Aboriginal and Torres Strait Islander Peoples.

Immunotherapy Trials
Led by Bendigo Regional Cancer Centre & Olivia Newton-John Cancer Centre
Increase regional trial participation in immunotherapy, and increase knowledge of side effects across regional workforce.
Immunotherapy is a cutting-edge cancer treatment that uses our immune system to fight cancer. It works by helping the immune system recognise and attack cancer cells.
Providing access to immunotherapy research, especially in cancers newer to immunotherapy interventions, represents a great potential improvement in health outcomes for regional Victorians.

Registry Trials
Led by Grampians Health Ballarat & Walter & Eliza Hall Institute (WEHI)
Increase number of trials at regional sites, increase engagment of regional clinicians in clinical trial design.
The primary purpose of registry trials is to better understand long term trends in specific patient populations. Gathering registry data from regional populations is a foundational step in ensuring that treatment is tailored to our specific patients, and not generalised from data gathered in city centres.
The Registry Trial initiative is the first step in understanding how our populations may be similar or different to those with similar diagnoses in metro areas.

Geriatric Oncology
Led by Border Medical Oncology Research Unit & LaTrobe University Wodonga
To Improve access among older adults to participate in oncology clinical trials, and to build capacity to conduct geriatric oncology clincal trials.
Successful care of older adults requires a multidiciplinary approach across community, primary, secondary and tertiary care providers.
The Geriatric Oncology initiative sets out to train, mentor and recruit those providers to assist and participate in geriatric oncology trials across regional, rural and remote Victoria.

Regional Research Teaching Hub
Co-Led By Border Medical Oncology Research Unit & Peter MacCallum Cancer Centre
The Regional Research Teaching Hub (RRTH) is a network developed with and for regional health professionals.
The RRTH exists to:
- Strengthen health services research capability and capacity across the regional cancer workforce, and
- Improve access to health services research resources and training for regional health professionals to impact regional health outcomes
The RRTH has developed the @research website to support health services research in the regional healthcare community.

